Drug Trial Radar · NCT00356915
Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
Last checked: Nov 19, 2026Latest source record: Feb 9, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,381
Actual
Start
Jul 2006
Primary completion
Oct 2008
Study completion Oct 2008
Sponsor
- Lead sponsor
- Stiefel, a GSK CompanyIndustry
- Sponsor type
- Industry
- Collaborators
- GlaxoSmithKline
- First posted
- Jul 27, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 16 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Onychomycosis is a common condition accounting for approximately half of all nail disorders. It is most commonly caused by dermatophytes. Itraconazole has been approved for the treatment of onychomycosis in the United States with an approved dosage regimen for the treatment of onychomycosis of the toenail of once daily (QD) treatment with 200mg of itraconazole (two 100 mg capsules) for 12 weeks. Barrier Therapeutics has developed a 200 mg tablet which could be used in a more convenient one-tablet-per-day dosing regimen. This clinical trial will compare the efficacy and safety of this new tablet formulation with itraconazole capsules and placebo.
Conditions
- Onychomycosis
Interventions
Itraconazole 100mg capsulesDrug
Subjects took two 100mg capsules once per day after a full meal. The dose dose was taken the day before the Week 12 visit.
Itraconazole 200mg tabletsDrug
Subjects took one 200mg tablet once per day after a full meal. The last dose was taken the day before the Week 12 visit.
Placebo tabletsDrug
Placebo tablets are the same as the Itraconazole tablets but without the active drug included. Subjects took one tablet once per day after a full meal. The last tablet was taken the day before the Week 12 visit.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical and Mycological Cure of Target ToenailTime frame: 1 year
- Complete Cure - Itraconazole Tablets Compared to Itraconazole CapsulesTime frame: 12 months
Locations
68 sites in 7 countries. Site status is shown where the registry gives one.
Radiant Research -Birmingham
Birmingham, Alabama
University of Alabama School of Medicine
Birmingham, Alabama
Radiant Research - Tucson
Tuscon, Arizona
Burke Pharmaceutical Research
Hot Springs, Arkansas
East Bay Dermatology Medical Group Inc.
Fremont, California
Skin Surgey Medical Group
San Diego, California
Therapeutics Clinical Research
San Diego, California
University of California
San Francisco, California
Radiant Research - Santa Rosa
Santa Rosa, California
Meridian Skincare
Englewood, Colorado
The Savin Center
New Haven, Connecticut
Dr. Stephen Horwitz
Aventure, Florida
International Dermatology Research Inc.
Miami, Florida
FMX Research Corporation
Miami, Florida
Advanced Dermatology and Cosmetic Surgery
Ormond Beach, Florida
Radiant Research - St. Petersburg
St. Petersburg, Florida
Radiant Research - West Palm Beach
West Palm Beach, Florida
Radiant Research - Atlanta West
Austell, Georgia
Gwinnett Clinical Research Center Inc.
Snellville, Georgia
Northwest Clinical Trials
Boise, Idaho
Radiant Research - Chicago
Chicago, Illinois
Radiant Research - Kansas City
Overland Park, Kansas
Dr. David Fivenson
Ann Arbour, Michigan
Skin and Vein Center
Troy, Michigan
Minnesota Clinical Study Center
Fridley, Minnesota
VA Medical Center
Minneapolis, Minnesota
Dr. Eduardo Tschen
Albuquerque, New Mexico
Skin Specialty Group
New York, New York
Columbia University Medical Center
New York, New York
Dermatology Consulting Services
High Point, North Carolina
Dermatology Clinical Research Center
Cincinnati, Ohio
Radiant Research - Cincinnati
Cincinnati, Ohio
Northwest Cutaneous Research
Portland, Oregon
Oregon Medical Research Center
Portland, Oregon
Rhode Island Hospital
Providence, Rhode Island
Radiant Research - Anderson
Anderson, South Carolina
Radiant Research - Greenville
Greenville, South Carolina
Dr. J. M. Humeniuk
Greer, South Carolina
Dermatology East
Germantown, Tennessee
Dermatology Associates of Knoxville
Knoxville, Tennessee
Showing 40 of 68 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.